Vanberra Signal

NatPro Pharmaceutical

Curated by Signal

Developer of chemotherapeutic drugs for the treatment of cancer

Overview

Developer of chemotherapeutic drugs for the treatment of cancer. It offers lead drug candidates inspired from potent natural products to treat patients with cancer and cancer resistant to chemotherapy. It has AI technology and molecular modelingplatform for drug discovery.

Key facts

Founded
2021

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Neurological imaging system

    Life Sciences TechnologySan Diego, United States
  • Provider of online tools for bioinformatics and data analysis

    Life Sciences TechnologySan Francisco, United States
  • Developer of antibodies for cardiometabolic and immune-mediated disease

    Life Sciences TechnologyBoston, United States

About NatPro Pharmaceutical

What does NatPro Pharmaceutical do?

Developer of chemotherapeutic drugs for the treatment of cancer.

Where is NatPro Pharmaceutical headquartered?

NatPro Pharmaceutical is headquartered in Brookings, United States.

When was NatPro Pharmaceutical founded?

NatPro Pharmaceutical was founded in 2021.

Which sector is NatPro Pharmaceutical in?

NatPro Pharmaceutical operates in Life Sciences Technology.

Who are NatPro Pharmaceutical's competitors?

Companies similar to NatPro Pharmaceutical include 4-D Neuroimaging, GenomeSmith, and AstralBio.